Supplemental Hydrogen Plus PQQ for Mitochondrial Biomarkers and Brain Function in Elderly With Mild Cognitive Impairment
CALERIE
The Effects of Six-week Hydrogen Plus Pyrroloquinoline Quinone (PQQ) Intake on Mitochondrial Biomarkers, Brain Metabolism and Cognition in the Elderly With Mild Cognitive Impairment
1 other identifier
interventional
34
1 country
1
Brief Summary
The goal of this randomized controlled double-blind parallel-group interventional trial is to evaluate the effects of dietary supplementation with molecular hydrogen and pyrroloquinoline quinone in elderly. The main questions it aims to answer are: (1) whether the supplementation affects biomarkers of mitochondrial function in serum, and (2) whether the supplementation affects cognition and brain metabolism. The participants will be subjected to take the dietary supplement during 6 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 8, 2023
CompletedFirst Posted
Study publicly available on registry
June 18, 2023
CompletedStudy Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2024
CompletedDecember 4, 2024
December 1, 2024
7 months
June 8, 2023
December 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Fibroblast growth factor 21
Level of fibroblast growth factor 21 in serum
Change from baseline serum fibroblast growth factor 21 at 6 weeks
Secondary Outcomes (6)
Peroxisome proliferator-activated receptor gamma coactivator 1-alpha
Change from baseline serum peroxisome proliferator-activated receptor gamma coactivator 1-alpha at 6 weeks
Brain-derived neurotrophic factor
Change from baseline serum brain-derived neurotrophic factor at 6 weeks
Irisin
Change from baseline serum irisin at 6 weeks
General cognition
Change from baseline MMSE score at 6 weeks
Brain creatine
Change from baseline brain creatine at 6 weeks
- +1 more secondary outcomes
Study Arms (2)
Supplement
EXPERIMENTALOne tablet of supplement before breakfast and dinner
Placebo
PLACEBO COMPARATOROne tablet of inert compound before breakfast and dinner
Interventions
Dietary supplement containing molecular hydrogen and pyrroloquinoline quinone
Eligibility Criteria
You may qualify if:
- Age \> 65 years
- MMSE scores ranged from 23-27
- Informed consent signed
You may not qualify if:
- Take part in exercise on a regular basis
- Severe chronic disease and acute injuries
- History of dietary supplement use during the past 4weeks
- No consent to randomization
- Participation in other studies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
FSPE Applied Bioenergetics Lab
Novi Sad, Vojvodina, 21000, Serbia
Related Publications (5)
Zanini D, Todorovic N, Korovljev D, Stajer V, Ostojic J, Purac J, Kojic D, Vukasinovic E, Djordjievski S, Sopic M, Guzonjic A, Ninic A, Erceg S, Ostojic SM. The effects of 6-month hydrogen-rich water intake on molecular and phenotypic biomarkers of aging in older adults aged 70 years and over: A randomized controlled pilot trial. Exp Gerontol. 2021 Nov;155:111574. doi: 10.1016/j.exger.2021.111574. Epub 2021 Oct 1.
PMID: 34601077BACKGROUNDOstojic SM. Does drinking water rich in hydrogen gas revive brain hypometabolism in neurodegeneration by SCFAs upregulation? Eur J Clin Nutr. 2021 Jan;75(1):212-213. doi: 10.1038/s41430-020-0680-x. Epub 2020 Jul 6. No abstract available.
PMID: 32632247BACKGROUNDKorovljev D, Stajer V, Javorac D, Ostojic SM. Hydrogen inhalation positively affects cardiometabolic risk factors in men and women aged 65 years or older: a preliminary report. Eur Geriatr Med. 2018 Oct;9(5):729-730. doi: 10.1007/s41999-018-0087-6. Epub 2018 Jul 31. No abstract available.
PMID: 34654221BACKGROUNDKorovljev D, Trivic T, Drid P, Ostojic SM. Molecular hydrogen affects body composition, metabolic profiles, and mitochondrial function in middle-aged overweight women. Ir J Med Sci. 2018 Feb;187(1):85-89. doi: 10.1007/s11845-017-1638-4. Epub 2017 May 30.
PMID: 28560519BACKGROUNDOstojic SM. Targeting molecular hydrogen to mitochondria: barriers and gateways. Pharmacol Res. 2015 Apr;94:51-3. doi: 10.1016/j.phrs.2015.02.004. Epub 2015 Feb 24.
PMID: 25720951BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 8, 2023
First Posted
June 18, 2023
Study Start
September 1, 2023
Primary Completion
March 15, 2024
Study Completion
March 31, 2024
Last Updated
December 4, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- Data requests can be submitted starting 9 months after article publication and the data will be made accessible for up to 24 months. Extensions will be considered on a case-by-case basis.
Data obtained through this study may be provided to qualified researchers with academic interest in age-related mild cognitive impairment. Data will be coded, with no PHI included. Approval of the request and execution of all applicable agreements are prerequisites to the sharing of data with the requesting party.